Press Release

Contraceptive Pills Market Global Industry Analysis, Potential Growth, Key Players, Latest Trends

Contraceptive Pills Market Worldwide Opportunities, Market Share, Key Players and Competitive Landscape

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

Request a Sample Copy of the Global Contraceptive Pills Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-pills-market-101802

Exciting Opportunities Await Local and Regional Players in the Market

While big companies such as Bayer AG are benefiting owing to their well-established presence, smaller players operating at the local and regional level are also slowly gaining ground in this market. This is a result of launching of innovative products by these players along with certain capacity restrictions hounding the large players.

Top Players Identified in the Contraceptive Pills Market Report by Fortune Business Insights:

  • Janssen Pharmaceutical Company
  • Piramal Enterprises
  • Allergan, plc
  • Mylan N.V.
  • Pfizer, Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries
  • HLL Lifecare Limited
  • Merck & Co., Inc.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contraceptive-pills-market-101802

Segmentation

By Type

  • Combines Contraceptives Pills
  • Progestin-only Pills

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Clinics
  • Online Channel
  • Public Channel & NGOs
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa ( South Africa, GCC, and Rest of Middle East & Africa)

 

Key Industry Developments:

  • December 2019: A team of scientists from the Massachusetts Institute of Technology (MIT) developed a contraceptive pill that needs to be taken only once a month. It is a gelatin capsule that releases synthetic hormones in the stomach, preventing unwanted pregnancy.
  • August 2017: Lupin Pharmaceuticals voluntarily recalled its contraceptive Mibelas 24 FE from the market in the U.S. as they were purportedly out of sequence.
Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close